Sentences with phrase «goal of therapies in»

The whole goal of therapies in autism is to train autistic children to be aware of the emotions of others.

I believe the goal of any therapy in autism is to find an effective channel for communication.

Not exact matches

As in all sound therapy, persons who come for help should be free to choose the goals of change.

In keeping with its broader spirit, this leadership in general recognizes abstinence as a worthy goal of therapIn keeping with its broader spirit, this leadership in general recognizes abstinence as a worthy goal of therapin general recognizes abstinence as a worthy goal of therapy.

The goal of Emmanuel therapy — to promote the freedom and growth of the individual by releasing inner resources, in contrast to authority - centered approaches, — is in keeping with the healthy needs of the alcoholic.

In fact, they may be more therapeutic than many «therapy groups» simply because they have a center outside themselves and a goal which is more inclusive than simply the growth of their members.

The goals of growth in gestalt therapy are really directions of continuing change.

The ultimate goal of TA therapy is «autonomy,» which is manifested in the recovery of three capacities — awareness, spontaneity, and intimacy.

The goal of therapy (and personal growth in general) is to activate and strengthen the will so that people learn to live intentionally.

Alyssa began her cranioscaral therapy training in the Spring of 2016 and looks forward to continuing her training in the coming months with the ultimate goal of working in Pediatrics as well as Prenatal, Birth and Post-Partum care.

With a caring, supportive, strengths - based focus, and a touch of humor, Colleen uses a variety of approaches and interventions such as Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), Eye Movement Desensitization and Reprocessing (EMDR), Play Therapy, Motivational Interviewing, Mindfulness and Harm Reduction Strategies in order to help clients achieve their goals, feel empowered and realize their full potential.

The goal of the current study was to conductg a brief review of the available scientific evidence for various therapies included in the MOON guidelines, and to provide the guidelines in their current form.

In most cases, a committee will determine the best course of therapy for each child, outlining the goals and objectives they would like to see the child accomplish.

A Gold Branch is a branch under the Association for Play Therapy that has obtained goals for trainings, networking, membership growth, RPT / S growth, and spreading the work of play therapy in the comTherapy that has obtained goals for trainings, networking, membership growth, RPT / S growth, and spreading the work of play therapy in the comtherapy in the community.

As the Founder of Molly and Me Counseling and Training Center, she has the goal of expanding play therapy across the state of Idaho by providing trainings in play therapy to professionals.

Because improved participation in «occupation» is pretty much always the end goal in occupational therapy, we have the privilege of being able to address the whole person when looking at what barriers are currently preventing them from being able to fully participate.

The center has supported thousands of women to achieve their breastfeeding goals since its inception, performed lactation research, provided education on lactation topics to both parents and professionals, advocated for changes in breastfeeding policies and provided lactation therapy for the treatment of infant sucking problems and maternal breast and nipple problems with an over 95 % success rate.

Fourteen GOP members of the Assembly support a ban on conversion therapy for minors as does Long Island Senator Phil Boyle, but the group's «primary goal» in the 2016 election «is to build a pro-GENDA majority in the State Senate.»

Unlike many clinical trials that emphasize relief of symptoms as their primary objective, the ezogabine study's goal is to gauge how well the therapy addresses some of the biological underpinnings of depression — in this case, whether the drug lessens the hyperactivity of the reward circuit that includes VTA neurons.

The outcomes of this work open new avenues of research with the goal of elucidating the biological mechanisms underlying asthma in relationship with environmental exposures and to promote the development of new therapies.

The goal is to identify new disease diagnostic markers and develop new therapies, according to the company's head of R&D in China, Andreas Tschirky, and chief scientific officer Li Chen.

Therapy may address specific forms of diagnosable mental illness, or everyday problems in relationships or meeting personal goals.

«In future research, specific drug therapies could be developed and tested with the goal of targeting this enzyme,» Wang said.

«We're at a pivotal point where we're building upon what we've learned in the PLAT - 02 trial and opening new trials, like PLAT - 04, with the goal of improving this therapy to the point that it becomes a long - term cure for all of our leukemia patients,» said Dr. Corinne Summers, an oncologist at Seattle Children's and the lead investigator of the PLAT - 04 trial.

«Identifying targets essential to cell survival in tumor suppressor genes has long been an investigational goal with the aim of offering cancer - specific vulnerabilities for targeted therapy,» said Ronald DePinho, M.D., professor of Cancer Biology, MD Anderson president, and senior author for the Nature paper.

The goal of such therapy is to extinguish fear, which is accomplished by presenting cues that are known to predict a negative experience in the absence of that experience.

The roadmap outlines future research directions toward the goal of enhancing human radioresistance, including upregulation of endogenous repair and radioprotective mechanisms, possible leeways into gene therapy in order to enhance radioresistance via the translation of exogenous and engineered DNA repair and radioprotective mechanisms, the substitution of organic molecules with fortified isoforms, the coordination of regenerative and ablative technologies, and methods of slowing metabolic activity while preserving cognitive function.

«As we are entering the era where we anticipate there will be many new treatments, each targeting inflammation differently, it is also important to understand the relative efficacy of these therapies in achieving our goal of mucosal healing to appropriately position them in our treatment algorithms,» said Dr. Ashwin Ananthakrishnan, senior author of the Alimentary Pharmacology & Therapeutics review.

Black said the researchers will aim to replicate these findings in additional patients and determine if and how the brain regions they identified may contribute to Tourette's syndrome, with a goal of developing more effective therapies.

Lynch says, «I think our results rationalise directed studies toward improving mitochondrial biogenesis as a long - term therapy in Friedreich's ataxia, and that the goals of therapy must include not only correcting iron - sulphur enzymes but also other mitochondrial dysfunction.

Nonetheless, an FDA press release described Zykadia as «a breakthrough therapy drug approved four months ahead of review completion goal date,» a message that was reflected in reporting by the Washington Post.

George notes, «Our goal in this trial was to evaluate the safety of the gene therapy product and secondarily, to determine if we could achieve levels of factor IX that could decrease bleeding events in patients.»

His laboratory at the German Cancer Research Center in Heidelberg and at the Medical Faculty Mannheim of Heidelberg University is studying the mechanisms of metastasis with the goal to develop more gentle supportive adjuvant therapies for tumor patients without detectable metastases following surgery of the primary tumor.

Srivastava said that since the FDA - approved fidarestat is available through a company in Japan, his eventual goal is to use a combination of fidarestat and doxorubicin to combat various forms of cancer including colon cancer with the hope that combination therapy will require less doxorubicin, which will reduce the potential for toxicity.

With miglustat therapy available off - label in the U.S. and potential therapies in clinical trials, the researchers said their goal is to see the test added to the recommended uniform screening panel defined by the U.S. Department of Health and Human Services (HHS).

A new model for post-integration latency in macroglial cells to study HIV - 1 reservoirs of the brain, AIDS, DOI: 10.1097 / QAD.0000000000000691 Link to the original publication As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases.

Our long - term goal, therefore, is to explore the potential to genetically disrupt both ccr5 and cxcr4 for cell replacement therapies in HIV infected individuals, and in the case of cxcr4 do so in a way that specifically targets CXCR4 on T cells and not the many other cell types on which it is expressed.

The goal of the Program in Human Gene Therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired diTherapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired ditherapy for the treatment of genetic and acquired diseases.

Scientists at the Gladstone Institutes are pursuing novel therapies to stop this cacophony in the brain with the goal of treating epilepsy, as well as seizure activity resulting from traumatic brain injury, stroke, or Alzheimer's disease.

The goal of our project is to determine the molecular factors responsible for pathology in AMD and to utilize that knowledge to develop therapies.

A traditional goal of salvage therapy in the refractory / relapsed population has been to transition patients to transplant, but in trials of inotuzumab and blinatumomab, there has been no clear impact on survival after censoring patients at the time of transplant.

Novel studies are already underway with the goal of preventing and managing relapse in the context of CAR T - cell therapy.

However, US FDA approval is only one step toward each developer's ultimate goal of a cell therapy that is sustainable, scalable, consistently high in quality, and manufacturable with a reasonable cost of goods (CoG).

The third Objective (IRF3) brings together promising scientists and clinicians from the University of Pennsylvania and the Rockefeller University to combine gene therapy strategies, independently tested in humans, with the goal of engineering, growing, and administering killer cells that are uniquely empowered to find and kill HIV - infected cells.

The results of her project will help scientists develop novel therapies to target the regulatory proteins that cause CD47 overproduction in leukemia and other cancer stem cells, with the goal of restoring immunosurveillance and enabling the immune system to recognize and destroy these aberrant cancer cells.

Since therapy is increasingly guided by the genetic aberrations in tumors, Herlyn and his colleagues are developing combinations of compounds that take into account the genetic signature of tumors, with the specific goal of individualized cancer therapy.

The goal of everyone in the HD community is to come up with effective therapies for the disease.

«The goals of maintenance therapy, as are the goals of all treatment in patients with advanced NSCLC, and perhaps all advanced cancers, is to prolong survival, and to improve or maintain quality of life,» said Gregory Kalemkerian, of the University of Michigan; he was not involved with the study.

My overarching goal in the lab is to determine the molecular basis of intraocular pressure and ultimately find targets that can be used to design therapies for glaucoma.

The goal of IRDiRC is to team up researchers and funding organizations across the world that are strongly involved in rare diseases research in order to achieve two main and ambitious objectives: deliver 200 new therapies for rare diseases and means to diagnose most rare diseases by the year 2020.